Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus
Top Cited Papers
- 1 June 2002
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 8 (6) , 594-599
- https://doi.org/10.1038/nm0602-594
Abstract
Epstein-Barr virus is ubiquitous and is causally implicated in lymphoid and epithelial malignancies. Virus invades oropharyngeal mucosa and establishes latency in B lymphocytes. Reactivating lymphocytes shed virus into saliva for spread to new hosts. A complex of three virus glycoproteins, gH, gL and gp42, is essential for entry. B-cell entry requires binding of gp42 to human leukocyte antigen (HLA) class II whereas entry into epithelial cells lacking HLA class II requires complexes without gp42. To accommodate infection of each, the virus carries both three-part and two-part complexes. We show here that HLA class II in the virus-producing cell alters the ratio of three-part to two-part complexes. As a consequence, virus originating in epithelial cells efficiently infects B cells whereas B-cell derived virus better infects epithelial cells. This molecular switch is a novel strategy that could alter tropism of virus from epithelium to B cells and then back to epithelium in a new host.Keywords
This publication has 33 references indexed in Scilit:
- Three Classes of Cell Surface Receptors for Alphaherpesvirus EntryVirology, 2000
- Coreceptor restriction within the HLA-DQ locus for Epstein–Barr virus infectionProceedings of the National Academy of Sciences, 2000
- Cellular Expression of Alphaherpesvirus gD Interferes with Entry of Homologous and Heterologous Alphaherpesviruses by Blocking Access to a Shared gD ReceptorVirology, 2000
- An Animal Model for Acute and Persistent Epstein-Barr Virus InfectionScience, 1997
- Lonely MHC molecules seeking immunogenic peptides for meaningful relationshipsCurrent Opinion in Cell Biology, 1995
- Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.The Journal of Experimental Medicine, 1994
- Epstein–Barr virus infection and replication in a human epithelial cell systemNature, 1992
- Epstein-barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosisCell, 1987
- Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.Proceedings of the National Academy of Sciences, 1984
- Specific antimononuclear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages.The Journal of Experimental Medicine, 1983